Trifunctional antibodies induce efficient antitumour activity with immune cells from head and neck squamous cell carcinoma patients after radio-chemotherapy treatment-Reference-Cited by-同舟云学术

Trifunctional antibodies induce efficient antitumour activity with immune cells from head and neck squamous cell carcinoma patients after radio-chemotherapy treatment

Published:2011-12 Issue:12 Volume:13 Page:889-898
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Schroeder Petra,Lindemann Carsten,Dettmar Kirsten,Brieger Jürgen,Gosepath Jan,Pogorzelski Benjamin,Seimetz Diane,Atz Judith

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12094-011-0751-5.pdf

Reference40 articles.

1. Köninki K, Barok M, Tanner M et al (2010) Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells. Cancer Lett 294:211–219

2. Ciavarella S, Milano A, Dammacco F, Silvestris F (2010) Targeted therapies in cancer. BioDrugs 24:77–88

3. Gall JM, Davol PA, Grabert RC et al (2005) T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro. Exp Hematol 33:452–459

4. Watanabe M, Wallace PK, Keler T et al (1999) Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210. Breast Cancer Res Treat 53:199–207

5. Wimberger P, Xiang W, Mayr D et al (2003) Efficient tumour cell lysis by autologous, tumourresident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody. Int J Cancer 105:241–248

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant-Produced Monoclonal Antibody as Immunotherapy for Cancer;BioMed Research International;2020-08-25

2. Immunotargeting and therapy of cancer by advanced multivalence antibody scaffolds;Journal of Drug Targeting;2020-06-09

3. Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment;Experimental Hematology & Oncology;2017-11-28

4. Blockage of EGFR Pathway for Anticancer Therapy in Squamous Cell Carcinoma of the Head and Neck;Squamous cell Carcinoma;2017

5. Catumaxomab (Removab) - Trifunctional Antibodies: Combining Direct Tumor Cell Killing with Therapeutic Vaccination;Handbook of Therapeutic Antibodies;2014-08-12